143 related articles for article (PubMed ID: 31478570)
21. miRNA-558 promotes tumorigenesis and aggressiveness of neuroblastoma cells through activating the transcription of heparanase.
Qu H; Zheng L; Pu J; Mei H; Xiang X; Zhao X; Li D; Li S; Mao L; Huang K; Tong Q
Hum Mol Genet; 2015 May; 24(9):2539-51. PubMed ID: 25616966
[TBL] [Abstract][Full Text] [Related]
22. High mobility group box 1-mediated autophagy promotes neuroblastoma cell chemoresistance.
Wang L; Zhang H; Sun M; Yin Z; Qian J
Oncol Rep; 2015 Dec; 34(6):2969-76. PubMed ID: 26397184
[TBL] [Abstract][Full Text] [Related]
23. FUBP1 promotes neuroblastoma proliferation via enhancing glycolysis-a new possible marker of malignancy for neuroblastoma.
Jiang P; Huang M; Qi W; Wang F; Yang T; Gao T; Luo C; Deng J; Yang Z; Zhou T; Zou Y; Gao G; Yang X
J Exp Clin Cancer Res; 2019 Sep; 38(1):400. PubMed ID: 31511046
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-203 inhibits the malignant progression of neuroblastoma by targeting Sam68.
Zhao D; Tian Y; Li P; Wang L; Xiao A; Zhang M; Shi T
Mol Med Rep; 2015 Oct; 12(4):5554-60. PubMed ID: 26136151
[TBL] [Abstract][Full Text] [Related]
25. The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway.
Flahaut M; Meier R; Coulon A; Nardou KA; Niggli FK; Martinet D; Beckmann JS; Joseph JM; Mühlethaler-Mottet A; Gross N
Oncogene; 2009 Jun; 28(23):2245-56. PubMed ID: 19421142
[TBL] [Abstract][Full Text] [Related]
26. Chemoresistance induces enhanced adhesion and transendothelial penetration of neuroblastoma cells by down-regulating NCAM surface expression.
Blaheta RA; Daher FH; Michaelis M; Hasenberg C; Weich EM; Jonas D; Kotchetkov R; Doerr HW; Cinatl J
BMC Cancer; 2006 Dec; 6():294. PubMed ID: 17181871
[TBL] [Abstract][Full Text] [Related]
27. Autophagy is associated with chemoresistance in neuroblastoma.
Belounis A; Nyalendo C; Le Gall R; Imbriglio TV; Mahma M; Teira P; Beaunoyer M; Cournoyer S; Haddad E; Vassal G; Sartelet H
BMC Cancer; 2016 Nov; 16(1):891. PubMed ID: 27846885
[TBL] [Abstract][Full Text] [Related]
28. Multiplex bioimaging of piRNA molecular pathway-regulated theragnostic effects in a single breast cancer cell using a piRNA molecular beacon.
Lee YJ; Moon SU; Park MG; Jung WY; Park YK; Song SK; Ryu JG; Lee YS; Heo HJ; Gu HN; Cho SJ; Ali BA; Al-Khedhairy AA; Lee I; Kim S
Biomaterials; 2016 Sep; 101():143-55. PubMed ID: 27289065
[TBL] [Abstract][Full Text] [Related]
29. piR-39980 mediates doxorubicin resistance in fibrosarcoma by regulating drug accumulation and DNA repair.
Das B; Jain N; Mallick B
Commun Biol; 2021 Nov; 4(1):1312. PubMed ID: 34799689
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-141 and its associated gene FUS modulate proliferation, migration and cisplatin chemosensitivity in neuroblastoma cell lines.
Wang Z; Lei H; Sun Q
Oncol Rep; 2016 May; 35(5):2943-51. PubMed ID: 26936280
[TBL] [Abstract][Full Text] [Related]
31. Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapy.
Brignole C; Bensa V; Fonseca NA; Del Zotto G; Bruno S; Cruz AF; Malaguti F; Carlini B; Morandi F; Calarco E; Perri P; Moura V; Emionite L; Cilli M; De Leonardis F; Tondo A; Amoroso L; Conte M; Garaventa A; Sementa AR; Corrias MV; Ponzoni M; Moreira JN; Pastorino F
J Exp Clin Cancer Res; 2021 Jun; 40(1):180. PubMed ID: 34078433
[TBL] [Abstract][Full Text] [Related]
32. A secondary structure within a human piRNA modulates its functionality.
Balaratnam S; Hettiarachchilage M; West N; Piontkivska H; Basu S
Biochimie; 2019 Feb; 157():72-80. PubMed ID: 30414834
[TBL] [Abstract][Full Text] [Related]
33. Intelectin 1 suppresses the growth, invasion and metastasis of neuroblastoma cells through up-regulation of N-myc downstream regulated gene 2.
Li D; Mei H; Pu J; Xiang X; Zhao X; Qu H; Huang K; Zheng L; Tong Q
Mol Cancer; 2015 Feb; 14():47. PubMed ID: 25889839
[TBL] [Abstract][Full Text] [Related]
34. Estrogen and Androgen Hormone Levels Modulate the Expression of PIWI Interacting RNA in Prostate and Breast Cancer.
Öner Ç; Turgut Coşan D; Çolak E
PLoS One; 2016; 11(7):e0159044. PubMed ID: 27414029
[TBL] [Abstract][Full Text] [Related]
35. The Shc protein RAI promotes an adaptive cell survival program in hypoxic neuroblastoma cells.
Criscuoli M; Filippi I; Osti D; Aldinucci C; Guerrini G; Pelicci G; Carraro F; Naldini A
J Cell Physiol; 2018 May; 233(5):4282-4293. PubMed ID: 29057481
[TBL] [Abstract][Full Text] [Related]
36. Knockdown of astrocyte elevated gene-1 inhibits proliferation and enhancing chemo-sensitivity to cisplatin or doxorubicin in neuroblastoma cells.
Liu H; Song X; Liu C; Xie L; Wei L; Sun R
J Exp Clin Cancer Res; 2009 Feb; 28(1):19. PubMed ID: 19216799
[TBL] [Abstract][Full Text] [Related]
37. NRP1 knockdown promotes the migration and invasion of human neuroblastoma-derived SK‑N‑AS cells via the activation of β1 integrin expression.
Ishizuka Y; Koshinaga T; Hirano T; Nagasaki-Maeoka E; Watanabe Y; Hoshi R; Yoshizawa S; Sugito K; Kawashima H; Uekusa S; Fukuda N; Soma M; Fujiwara K
Int J Oncol; 2018 Jul; 53(1):159-166. PubMed ID: 29750423
[TBL] [Abstract][Full Text] [Related]
38. Perhexiline maleate enhances antitumor efficacy of cisplatin in neuroblastoma by inducing over-expression of NDM29 ncRNA.
Vella S; Penna I; Longo L; Pioggia G; Garbati P; Florio T; Rossi F; Pagano A
Sci Rep; 2015 Dec; 5():18144. PubMed ID: 26674674
[TBL] [Abstract][Full Text] [Related]
39. PIWI-interacting RNA 021285 is involved in breast tumorigenesis possibly by remodeling the cancer epigenome.
Fu A; Jacobs DI; Hoffman AE; Zheng T; Zhu Y
Carcinogenesis; 2015 Oct; 36(10):1094-102. PubMed ID: 26210741
[TBL] [Abstract][Full Text] [Related]
40. Novel MDM2 inhibitor SAR405838 (MI-773) induces p53-mediated apoptosis in neuroblastoma.
Lu J; Guan S; Zhao Y; Yu Y; Wang Y; Shi Y; Mao X; Yang KL; Sun W; Xu X; Yi JS; Yang T; Yang J; Nuchtern JG
Oncotarget; 2016 Dec; 7(50):82757-82769. PubMed ID: 27764791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
